Showing 341 - 360 results of 4,209 for search 'far is (((((evolves. OR involves.) OR involves.) OR resolvesdsds.) OR involved.) OR revolves.)', query time: 0.89s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350

    Presentation_2_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  11. 351

    Presentation_4_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  12. 352

    Presentation_1_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  13. 353

    Table_1_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II)2Cys6... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  14. 354

    Presentation_3_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  15. 355

    Table_2_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II)2Cys6... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  16. 356

    Table_3_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II)2Cys6... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  17. 357

    Table_4_Utilization of ferulic acid in Aspergillus niger requires the transcription factor FarA and a newly identified Far-like protein (FarD) that lacks the canonical Zn(II)2Cys6... by Mark Arentshorst (436897)

    Published 2022
    “…The ΔfarA transcription factor mutant, already known to be involved in fatty acid metabolism, could not utilize ferulic acid and other hydroxycinnamic acids. …”
  18. 358
  19. 359

    Epistasis does not evolve in the simple LP model. by Jon F. Wilkins (527368)

    Published 2016
    “…(D) Simulated time course of a population evolving along the optimal-fitness ridge indicated by the green dashed lines in C. …”
  20. 360

    The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients by Li-Kuo Huang (4117453)

    Published 2017
    “…Furthermore, diabetics with HbA1c > 8% were more likely to exhibit unusual findings (<i>P <</i> 0.001), far advanced extensive lesions (<i>P</i> < 0.001) on CXRs, lymphadenopathy (<i>P</i> = 0.028), more than one cavity in a single lesion (<i>P</i> < 0.001) and all lobe involvement (<i>P</i> = 0.041) on thoracic CT scans.…”